Targeting proteins to treat diabetic retinopathy – COMPLETED
Scientific title: Targeting STAT3 for the management of diabetic retinopathy
Principal Investigator: Dr Heping Xu
Institution: Queen’s University Belfast
Project duration: 01/07/2014 – 31/12/2016
Objective: This project is investigating a protein called STAT3 for its role in diabetic retinopathy. STAT3 is involved in the processes that cause inflammation in the body, and evidence suggests that inflammation contributes to the damage caused by diabetic retinopathy. Dr Xu and his team hope that limiting the production or effects of STAT3 could lead to a treatment for diabetic retinopathy.
Categories: Treat, Strategic Research Agreement, Complications